Cassava Sciences (NASDAQ: SAVA) stock price has been in a steep sell-off in the past few months as the enthusiasm of its pipeline wanes. Shares of the biopharmaceutical company were trading at $24.9 o...
Tag: Sciences
For Nvidia Stock, It’s Game On!
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
Sellas Life Sciences raises $20 million from public offering of stock, warrants
Sellas Life Sciences Group Inc. SLS, -53.25% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy stock. Shares of the biopharmaceutical company, whic...
AI Becomes Silicon Valley’s Next Buzzy Bandwagon as Crypto Boom Fizzles
The new artificial-intelligence tools getting widespread attention for spitting out text, images and computer code are also generating something else: talk of the next technology bubble. Technologists...
AI is dominating the action in the stock market right now
OpenAI, the developer of ChatGPT, is receiving billions of dollars in funding from Microsoft Corp. MSFT, -0.20%. The rollout of this new technology has been followed by similar efforts by Alphabet Inc...
ChatGPT Has Sparked an AI Craze. How to Build a Long-Term AI Portfolio.
Artificial intelligence has sparked new competition in internet search—for the first time in decades. Here’s how to build an AI portfolio. Feb. 10, 2023 6:06 pm ET It has been more than 70 years...
Nvidia, Broadcom, and Marvell Are Chip Stocks to Benefit in AI Arms Race
J.P. Morgan says there are three semiconductor companies that will thrive from the rising demand for artificial-intelligence services and software. In a note to clients on Friday, analyst Harlan Sur s...
These 20 AI stocks are expected by analysts to rise up to 85% over the next year
There are always fads in the stock market, but now we are in the midst of what could turn out to be a revolutionary trend that will last much longer than any fad — artificial intelligence. In the Need...
Danaher Takes Interest in Life Sciences Firm Catalent
(Bloomberg) — Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg T...
China’s Baidu Plans a ChatGPT Rival. The Internet Giant’s Stock Could Reap the Returns.
Talk about buying the rumor. Baidu China’s leading internet search provider, let it be known on Jan. 30 that it will launch a so-called chatbot powered by artificial intelligence, akin to the ChatGPT ...
Cathie Wood: Ark Continues Exact Sciences Dump
Famed investor Cathie Wood, chief executive of Ark Investment Management, keeps unloading what was the No. 1 holding in Ark’s flagship fund. Ark funds sold 683,698 shares of Exact Sciences (EXAS) ...
Why the Dip in Cassava Sciences (SAVA) Stock Shouldn’t Spook You
Investors did not like the latest update from Alzheimer’s drug maker Cassava Sciences (NASDAQ:SAVA). After showing excellent results from the first 50 patients treated with simufilam, the compan...
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Top Dividend Stock: Gilead Sciences Nears Buy Point Ahead of Earnings
IBD’s Income Investor highlights top dividend stocks. This week, we look at Gilead Sciences (GILD) as the drug giant nears a buy point amid continued stability and a growing dividend. X Gilead ...
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
The Craziest Moments From the Longest Tech Boom (So Far)
It’s been a singular year for tech, one that marked the apparent end to a heady, madcap boom that changed how we think about the industry. Over the past dozen or so years, a tidal wave of money poure...
Opinion: 11 predictions for money, technology, stocks and crypto for 2023
Here are some 2023 predictions for financial markets, the economy and stocks. I’ve spent the last year and a half being cautious in the wake of the Bubble-Blowing Bull Market that finally ended early ...
ChatGPT is called ‘an iPhone moment in AI,’ but will it make money like the iPhone?
ChatGPT is the latest product of artificial intelligence to take away Silicon Valley’s breath (and venture-capital investments), but it is also yet another AI advancement that has not proved its abili...
Earn extra money with a side gig—here are 6 good ones for retirees
If inflation and the gyrating stock market has you fretting over your financial security in retirement, you’re not alone. Fully 71% of boomers recently surveyed by Bankrate said they are behind on ret...
Gilead Sciences, Moderna, Tesla and more
A sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Justin Sullivan | Getty Images Check out the companies making the biggest moves midday: Gene...
First Outside Investment In 30 Years Makes Life Sciences Software Firm A Unicorn
MasterControl CEO Jon Beckstrand Austen Diamond Photograhy Most software startups seek venture funding in the early stages. MasterControl, which provides quality and manufacturing software for life sc...
Opinion: Microsoft invested in an AI system that helped me write this column about Tesla
Can an artificial intelligence system help me write articles about investment ideas? Let’s find out. There are two subjects I would like to cover. But I will have help, and as a result there is a thir...
Nvidia Stock Can Endure a Slowdown, Analyst Says. AI Is Key.
Nvidia should be insulated from any slowdown in the broader economy by increased spending on artificial intelligence, said analysts at Oppenheimer and KeyBanc, who lifted their price targets on shares...